~~<i id='CF15D175F8'><strike id='CF15D175F8'><tt id='CF15D175F8'><pre id='CF15D175F8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

focus

author：Wikipedia 2025-10-01 17:21:09 - browse：142

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： WHO recommends second malaria vaccine

hotspot

knowledge

hotspot

focus

Wikipedia

entertainment

RyanPierse/GettyImagesHereisSTAT’sbiotechscorecard,ourregularledgerofstock-movingbiotechevents,forth

WSS

Experts study whether long Covid risk adds up with each reinfection

A single drug, study failures leave Anavex with nothing but cash

Some top drug companies are starting to take action on climate

What will Novo Nordisk's VC do with its influx of cash?

3 medical device trends to watch in 2024

Feng Zhang CRISPR delivery startup lays off quarter of staff

leisure time

focus

hotspot

Alkermes shareholders re

Study points to new risk in gene therapy death of Terry Horgan

In Memoriam: Notable people who died in 2023

Health insurers' Q3 question: how much care are people getting?

Affirmative action in medical school literally saved lives

CRISPR base editing slashes cholesterol levels in monkeys

23andMe had bad news about my health. I wish a person had delivered it

Experts study whether long Covid risk adds up with each reinfection

Medicare details structure of new drug price negotiation program

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

knowledge

Health insurers' Q3 question: how much care are people getting?

Medicare innovation center doesn’t save money, experts say

The United States is paying nearly triple for new Covid vaccines

European officials brace for rough respiratory virus season

CDC picks Alphabet's Verily for wasterwater surveillance contract

Medicare innovation center doesn’t save money, experts say

hotspot

focus

Wikipedia

entertainment